Remus Pharmaceuticals Stock Performance

as on June 10, 2026 at 9:31 pm IST

Day's Low
Day's High
₹680.00
Day's Price Range
₹694.00
₹680.50
0.07%
Downside
1.98%
Upside
52 Week's Low
52 Week's High
₹580.00
52-Week Price Range
₹1,021.80
₹680.50
14.77%
Downside
50.15%
Upside

Remus Pharmaceuticals share price movements today

Previous Close: ₹690.25
Open: ₹694.00
Volume: 2,400.00
Upper Circuit: ₹828.30
Lower Circuit: ₹552.20
Day's Low - High: ₹680.00 - ₹694.00
52 Week Low - High: ₹580.00 - ₹1,021.80

Remus Pharmaceuticals Historical Returns

1 Month Return: -8.51 %
3 Month Return: + 13.94 %
1 Year Return: -29.51 %
3 Year Return: + 113.37 %
5 Year Return: + 207.32 %

Remus Pharmaceuticals Fundamentals

as on June 10, 2026 at 4:01 pm IST

Market Cap

₹928.51 Cr

Return on Equity (ROE)

18.3

PE Ratio (TTM)

20.26

Return on capital employed (ROCE)

19.97

Beta (LTM)

1.23

P/B Ratio

14.43

Dividend Yield

PEG Ratio

-7.06

Quarterly Earnings Growth YOY

EPS (TTM)

9.32

Book Value

217.2

Remus Pharmaceuticals Technical Analysis

Track how Remus Pharmaceuticals technical analysis has moved over time to understand its trends.

1 min

5 min

15 min

30 min

1 day

1 week

1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish12

Bullish1

Neutral2

Oscillators

Name	Value	Action
MACD level (12,26)	-1.37	Bearish
CCI (20)	-66.33	Neutral
RSI (14)	25.13	Bullish
Momentum (10)	-5.5	Neutral
ADI (14)	73.98	Bearish
Ultimate Oscillator (7,14,28)	11.61	Bearish

Moving Averages

Name	Value	Action
SMA (20)	683.72	Bearish
EMA (20)	682.79	Bearish
VWMA (20)	682.31	Bearish
SMA (50)	684.09	Bearish
EMA (50)	683.93	Bearish
SMA (200)	688.72	Bearish
EMA (200)	687.46	Bearish
KAMA (200)	686.15	Bearish
DEMA (200)	683.81	Bearish

Remus Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Remus Pharmaceuticals with its industry peers.

Company	Analyst View	Market Cap(in ₹ Cr)	5 Year CAGR	Debt to Asset Ratio	Net Profit(in ₹ Cr)	Yearly Revenue(in ₹ Cr)
Wanbury Ltd	NA	928.51	30.33%	0.88	30	599
Bharat Parenterals Ltd	NA	0.00	47%	0.69	-44	340
Bafna Pharmaceuticals Ltd	NA	412.99	4.63%	0.00	4	145
Aarti Pharmalabs Ltd	HOLD	5,668.38	23.38%	0.59	272	2,115
Shree Ganesh Remedies Ltd	NA	0.00	24.45%	0.61	23	108

See all

Remus Pharmaceuticals Stock’s Investor Sentiment and Interest

Search interest for Remus Pharmaceuticals Ltd Stock has increased by 412% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 12, 2026 to June 11, 2026

Change:412% versus previous 30 day period

Remus Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

	Mar 2024	Mar 2025	Mar 2026
Sales	212.94	620.36	853.63
Other Income	2.83	4.98	6.7
Total Income	215.77	625.34	860.33
Expenses	183.98	574.67	796.94
Operating Profit	28.96	45.69	56.69
Operating Profit Margin %	13.6%	7.37%	6.64%
Profit Before Interest, Tax and Depreciation	31.79	50.67	63.39
Interest	0.5	1.46	1.47
Depreciation	1.12	1.87	2.76
Profit Before Tax	30.17	47.34	59.16
Tax Paid	5.89	8.92	12.99
Profit After Tax	24.28	38.42	46.17
Total Net profit including share of profit / Loss from associate company	24.28	38.42	46.17
EPS	42.97	65.21	39.19
Actual EPS	42.97	65.21	39.19
Adjusted EPS	5.37	32.6	39.19
Diluted EPS	42.97	65.21	39.19

Remus Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

	Mar 2024	Mar 2025
Net Cash from Operating Activities	1.35	6.99
Cash Flow from Investing Activities	-25.31	-10.55
Cash Flow from Financing Activities	27.67	6.07
Net Cash Flow	3.71	2.51

Remus Pharmaceuticals Stock Shareholding Pattern

Numbers in percentages

	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jul 2025	Sep 2025	Mar 2026
Promoters	69.61%	70.6%	70.66%	70.84%	70.85%	70.85%	70.91%	70.95%
DII	0%	0%	0%	0%	0%	0%	0%	0.83%
FII	0%	0%	0%	0%	0%	0%	0%	5.28%
Public	27.3%	25.49%	25.61%	25.22%	23.6%	23.32%	23.31%	22.93%
Total Outstanding Shares	14,73,000	14,73,000	58,92,000	58,92,000	58,92,000	1,17,84,000	1,17,84,000	1,17,84,000
Total Shareholders	856	1,124	1,577	1,753	398	2,017	2,032	2,009

Insights on Remus Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 5.02% to 5.28% in Mar 2026 quarter
POSITIVE IMPACT
Promoter Holding Up
Promoters have increased holdings from 70.91% to 70.95% in Mar 2026 quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, REMUS stock has moved down by -5.3%
NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 23.31% to 22.93% in Mar 2026 quarter

About Remus Pharmaceuticals Ltd

Remus Pharmaceuticals Limited, originally incorporated as Remus Pharmaceuticals Private Limited in 2015, is engaged in the marketing and distribution of finished formulations of pharmaceutical drugs. It deals in various drug forms such as capsules, creams, gel, injection, tablets, etc. and supplies therapeutic drugs like ACE inhibitors, anaesthetics, antihistamines, anticancer, etc. Remus Pharmaceuticals' core business includes manufacturing approved finished formulations through loan licence and contract manufacturing, trading of Active Pharmaceutical Ingredients and Technical Consultancy on preparation of reports on pharmaceutical dossiers. It has a product portfolio of 429 products, 58 domestic distributors and 139 international distributors. Currently, the company is proposing an initial public offering of up to 388000 Equity Shares through its Fresh Issue.

Listing date: 29 May, 2023

Organisation	Remus Pharmaceuticals Ltd
Industry	Pharmaceuticals
E-voting on shares	Click here to vote

FAQs

What is Remus Pharmaceuticals share price today?

Remus Pharmaceuticals share price today stands at ₹680.5 as on June 10, 2026 at 4:01 pm IST at the close of the market. Remus Pharmaceuticals share today touched a day high of ₹694 and a low of ₹680.

What is the 52 week high and 52 week low range for Remus Pharmaceuticals share?

Remus Pharmaceuticals touched a 52 week high of ₹1021.8 and a 52 week low of ₹580. Remus Pharmaceuticals share price today i.e. June 10, 2026 at 4:01 pm IST is closed at ₹680.5, which is -33.40% down from its 52 week high and 17.33% up from its 52 week low.

What is Remus Pharmaceuticals's market capitalisation today?

Remus Pharmaceuticals market capitalisation is ₹813.39 Cr as on June 10, 2026 at 4:01 pm IST.

How to buy Remus Pharmaceuticals shares?

To buy Remus Pharmaceuticals shares, you need to follow these steps:

Open a Demat account and Trading account on INDmoney
Fund your Trading account
Search for REMUS or Remus Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
Click on Buy or SIP to place an order to invest in Remus Pharmaceuticals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Remus Pharmaceuticals trading volume today?

Remus Pharmaceuticals trading volume is 2,400.00 as on June 10, 2026 at 4:01 pm IST. This means that 2,400.00 shares of Remus Pharmaceuticals were bought and sold on the stock market during today's trading session.